Pengcheng Zhang Selected Research

Pengcheng Zhang Research Topics

Disease

57	Neoplasms (Cancer) 04/2024 - 06/2012
14	Neoplasm Metastasis (Metastasis) 08/2022 - 01/2016
10	Breast Neoplasms (Breast Cancer) 02/2019 - 03/2015
6	Triple Negative Breast Neoplasms 02/2024 - 11/2017
6	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2016
5	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 06/2012
4	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 01/2022
4	Brain Neoplasms (Brain Tumor) 01/2021 - 01/2016
3	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 08/2019
3	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2022 - 12/2014
2	Lung Injury 02/2024 - 01/2018
2	Parkinson Disease (Parkinson's Disease) 01/2024 - 10/2019
2	Lung Neoplasms (Lung Cancer) 12/2023 - 12/2020
2	Adenocarcinoma of Lung 01/2023 - 01/2023
2	Fibrosis (Cirrhosis) 01/2023 - 01/2022
2	Inflammation (Inflammations) 09/2022 - 04/2016
2	Non-alcoholic Fatty Liver Disease 01/2022 - 04/2016
2	Liver Neoplasms (Liver Cancer) 01/2021 - 01/2019
2	Hemolysis 01/2020 - 05/2012
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2014 - 04/2013
1	Wounds and Injuries (Trauma) 04/2024
1	Pneumoperitoneum 01/2024
1	Renal Cell Carcinoma (Grawitz Tumor) 08/2023
1	Squamous Cell Carcinoma of Head and Neck 01/2023

Drug/Important Bio-Agent (IBA)

8	Peptides (Polypeptides)IBA 10/2023 - 04/2013
7	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2019
6	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2021
6	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2021 - 02/2013
5	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2022 - 04/2013
5	HydrogelsIBA 01/2021 - 11/2017
5	ProdrugsIBA 01/2021 - 01/2016
4	LigandsIBA 09/2022 - 01/2016
4	CarbonIBA 01/2022 - 10/2018
4	GoldIBA 01/2021 - 01/2016
4	mesoglycanIBA 10/2020 - 10/2019
3	HDL LipoproteinsIBA 02/2024 - 01/2019
3	Therapeutic UsesIBA 01/2023 - 01/2021
3	Immune Checkpoint InhibitorsIBA 01/2023 - 02/2019
3	InterferonsIBA 09/2022 - 01/2019
3	IonsIBA 01/2022 - 10/2018
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2020 - 01/2016
3	Paclitaxel (Taxol)FDA LinkGeneric 12/2017 - 06/2012
3	MicellesIBA 03/2015 - 05/2012
2	AntioxidantsIBA 04/2024 - 01/2015
2	EnzymesIBA 04/2024 - 01/2020
2	MicroRNAs (MicroRNA)IBA 12/2023 - 01/2021
2	IntegrinsIBA 10/2023 - 06/2012
2	AcidsIBA 01/2023 - 01/2016
2	triptolideIBA 01/2023 - 09/2019
2	vadimezanIBA 09/2022 - 01/2019
2	Tyrosine Kinase InhibitorsIBA 09/2022 - 01/2014
2	Liposomes (Liposome)IBA 08/2022 - 11/2017
2	Sirtuin 1IBA 01/2022 - 01/2015
2	GenisteinIBA 01/2021 - 10/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2018
2	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 01/2021 - 10/2018
2	CamptothecinIBA 10/2020 - 01/2016
2	AntigensIBA 02/2020 - 01/2020
2	Sincalide FDA Link 01/2020 - 01/2019
2	Silicon Dioxide (Silica)FDA LinkGeneric 01/2020 - 01/2017
2	Circular RNAIBA 08/2019 - 01/2019
2	BerberineIBA 01/2019 - 12/2014
2	Radiation-Sensitizing AgentsIBA 01/2019 - 01/2016
2	Cisplatin (Platino)FDA LinkGeneric 07/2018 - 01/2016
2	MetalsIBA 01/2018 - 01/2016
2	Ethanol (Ethyl Alcohol)IBA 12/2017 - 01/2015
2	Peptide Hydrolases (Proteases)FDA Link 01/2017 - 03/2016
2	demethyleneberberineIBA 04/2016 - 01/2015
2	AMP-Activated Protein KinasesIBA 04/2016 - 01/2015
2	Fatty Acids (Saturated Fatty Acids)IBA 04/2016 - 01/2015
2	Coloring Agents (Dyes)IBA 01/2016 - 03/2014
1	PlasticsIBA 04/2024
1	Ciprofloxacin (Cipro)FDA LinkGeneric 04/2024
1	ChromatinIBA 04/2024
1	Adenosine Triphosphate (ATP)IBA 02/2024
1	Adenosine (Adenocard)FDA LinkGeneric 02/2024
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 02/2024
1	alpha-SynucleinIBA 01/2024
1	Proline (L-Proline)FDA Link 12/2023
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2023
1	Fas Ligand Protein (Fas Ligand)IBA 10/2023
1	Antisense RNA (Anti-Sense RNA)IBA 08/2023
1	Ursolic AcidIBA 08/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2023
1	Long Noncoding RNAIBA 08/2023
1	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 01/2023
1	Interleukin-2 (IL2)IBA 01/2023
1	AndrogensIBA 01/2023

Therapy/Procedure

29	Therapeutics 04/2024 - 06/2012
14	Drug Therapy (Chemotherapy) 02/2024 - 06/2012
12	Immunotherapy 01/2023 - 01/2016
6	Radiotherapy 02/2024 - 01/2016
5	Photochemotherapy (Photodynamic Therapy) 01/2020 - 01/2016
4	Lasers (Laser) 01/2020 - 01/2017
3	Injections 12/2020 - 11/2017
3	Precision Medicine 01/2020 - 01/2016
2	Transplantation 01/2023 - 07/2021
1	Microspheres (Microsphere) 04/2024
1	Lymph Node Excision (Lymph Node Dissection) 01/2024
1	Operative Time 01/2024